Inactivated Vaccines Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends

What Is the Forecasted Market Size and Growth Rate for the Inactivated Vaccines Market?
The inactivated vaccines market will grow from $6.19 billion in 2024 to $6.44 billion in 2025, with a CAGR of 4.0%. Growth is driven by polio eradication efforts, influenza vaccination programs, emerging infectious diseases, and regulatory approvals.

The Inactivated Vaccines market will grow to $7.75 billion by 2029 at a CAGR of 4.7%, driven by pandemic preparedness, vaccine expansion, and advancements in biomanufacturing. Trends include mRNA vaccine platforms and digital vaccine passports.

What Factors Are Propelling the Expansion of the Inactivated Vaccines Market?
The rising prevalence of infectious diseases is expected to drive the growth of the inactivated vaccine market in the future. Infectious diseases are caused by pathogens such as bacteria, viruses, fungi, or parasites, which can spread from person to person and result in various symptoms and health complications. Tuberculosis is an example of an infectious disease. Inactivated vaccines use non-living pathogens to trigger an immune response, effectively preventing diseases like polio, hepatitis A, and influenza. For instance, in November 2023, the Centers for Disease Control and Prevention, a US-based public health agency, reported that the number of tuberculosis cases in the USA had risen from 8,320 in 2022 to 9,615 in 2023, showing an increase of 1,295 cases. As such, the increasing prevalence of infectious diseases is driving the growth of the inactivated vaccine market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13018&type=smp

Which Businesses Are at the Forefront of Inactivated Vaccines Market Development?
Major companies operating in the inactivated vaccines market are Pfizer Inc., Johnson & Johnson Services Inc., Sinopharm Group Co. Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., CSL Limited, Daiichi Sankyo Company Limited, Mitsubishi Tanabe Pharma Corporation, Novavax Inc., Zydus Lifesciences Ltd., Sinovac Biotech Ltd., Biological E Limited, Hualan Biological Engineering Inc., CanSino Biologics Inc., Shenzhen Kangtai Biological Products Co. Ltd., Serum Institute of India Pvt. Ltd., Beijing Tiatan Biological Products Co. Ltd., Valneva SE, Bavarian Nordic A/S., Beijing Minhai Biotechnology Co. Ltd., Bharat Biotech International Limited, Panacea Biotec Ltd., Sinergium Biotech SA, Bharat Immunologicals and Biologicals Corporation Limited, Haffkine Biopharmaceutical Corporation Limited, Incepta Vaccine Ltd., Changchun BCHT Biotechnology Co. Ltd., .

What Are the Latest Innovations in the Inactivated Vaccines Market?
Major players in the inactivated vaccines market are continuously developing innovative inactivated vaccines to maintain their market share. An inactivated vaccine contains dead virus particles, bacteria, or other pathogens that have been cultured and killed to eliminate their disease-causing ability. For example, in January 2022, GSK PLC, a UK-based pharmaceutical company, introduced a new inactivated vaccine named Shingrix for shingles protection. This non-live, recombinant subunit vaccine is administered in two intramuscular doses and initially targeted individuals aged 50 and older. Recently, its use was extended to those 18 and older at a higher risk due to immunodeficiency or immunosuppressive treatments.

How Is the Inactivated Vaccines Market Segmented?
The inactivated vaccines market covered in this report is segmented -

1) By Type: Viral Vaccine, Bacterial Vaccine
2) By Method Of Inactivation: Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

Subsegments:
1) By Viral Vaccine: Inactivated Poliovirus Vaccine (IPV), Inactivated Influenza Vaccine, Inactivated Hepatitis A Vaccine, Inactivated Rabies Vaccine
2) By Bacterial Vaccine: Inactivated Typhoid Vaccine, Inactivated Cholera Vaccine, Inactivated Pertussis Vaccine, Inactivated Plague Vaccine

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report

Where Is the Inactivated Vaccines Market Growth Most Prominent?
North America was the largest region in the inactivated vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in inactivated vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Is Covered In The Inactivated Vaccines Global Market Report?

- Market Size Analysis: Analyze the Inactivated Vaccines Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Inactivated Vaccines Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Inactivated Vaccines Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Inactivated Vaccines Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.